{"id":24679,"date":"2023-11-28T19:37:00","date_gmt":"2023-11-28T19:37:00","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=24679"},"modified":"2026-03-19T14:44:52","modified_gmt":"2026-03-19T21:44:52","slug":"opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/","title":{"rendered":"Opdivo: Un f\u00e1rmaco vers\u00e1til que combate m\u00faltiples tipos de c\u00e1ncer"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#What_Is_Opdivo\" >\u00bfQu\u00e9 es Opdivo?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#What_Is_Opdivo_Used_To_Treat\" >\u00bfPara qu\u00e9 se utiliza Opdivo?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#How_Does_Opdivo_Work\" >\u00bfC\u00f3mo funciona Opdivo?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#Dosage_Form_and_Strengths\" >Forma farmac\u00e9utica y concentraciones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#Dosage\" >Dosificaci\u00f3n<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#Dosing_Information\" >Informaci\u00f3n de dosificaci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#As_a_Single_Agent_Monotherapy\" >Como agente \u00fanico (monoterapia)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#Combined_With_Other_Therapies\" >Combinado con otras terapias<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#How_Is_Opdivo_Administered\" >\u00bfC\u00f3mo se administra Opdivo?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#Side_Effects\" >Efectos secundarios<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#Precautions_When_Taking_Opdivo\" >Precauciones al tomar Opdivo<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#Cost\" >Costo<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-opdivo\"><span class=\"ez-toc-section\" id=\"What_Is_Opdivo\"><\/span>\u00bfQu\u00e9 es Opdivo?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Opdivo es un nombre comercial para el medicamento nivolumab, que es un tipo de f\u00e1rmaco de inmunoterapia que se usa para tratar ciertos tipos de c\u00e1ncer. Opdivo fue aprobado por primera vez por el&nbsp;<a href=\"https:\/\/www.fda.gov\/\">FDA<\/a>&nbsp;En 2014, se utiliz\u00f3 para tratar el melanoma avanzado que no responde a otros tratamientos. Desde entonces, el Opdivo ha sido aprobado para varios otros tipos de c\u00e1ncer gracias a los resultados positivos de sus ensayos cl\u00ednicos, que respaldan su seguridad y eficacia en el tratamiento de diversos tipos de c\u00e1ncer.<\/p>\n\n\n\n<p>Este medicamento de inmunoterapia pertenece a la clase de f\u00e1rmacos anti-muerte celular programada-1 (PD-1), que ataca y bloquea principalmente la actividad de prote\u00ednas espec\u00edficas que suprimen el sistema inmunol\u00f3gico.<\/p>\n\n\n\n<p>Opdivo solo est\u00e1 disponible con receta m\u00e9dica y viene en una soluci\u00f3n inyectable en vial de dosis \u00fanica.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-is-opdivo-used-to-treat\"><span class=\"ez-toc-section\" id=\"What_Is_Opdivo_Used_To_Treat\"><\/span>\u00bfPara qu\u00e9 se utiliza Opdivo?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Desde la primera aprobaci\u00f3n de Opdivo hasta ahora, la FDA ha aprobado el uso de Opdivo en el tratamiento de varios tipos de c\u00e1ncer, que incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Melanoma (c\u00e1ncer de piel avanzado)<\/li>\n\n\n\n<li>C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as metast\u00e1sico<\/li>\n\n\n\n<li>Carcinoma de c\u00e9lulas escamosas de cabeza y cuello<\/li>\n\n\n\n<li>Linfoma de Hodgkin cl\u00e1sico (c\u00e1ncer de linfocitos)<\/li>\n\n\n\n<li>carcinoma hepatocelular (c\u00e1ncer de h\u00edgado)<\/li>\n\n\n\n<li>Carcinoma urotelial (c\u00e1ncer de vejiga y v\u00edas urinarias)<\/li>\n\n\n\n<li>Carcinoma de c\u00e9lulas renales avanzado (c\u00e1ncer de ri\u00f1\u00f3n)<\/li>\n\n\n\n<li>C\u00e1ncer colorrectal (c\u00e1ncer de intestino)<\/li>\n\n\n\n<li>C\u00e1ncer de es\u00f3fago (c\u00e1ncer que se desarrolla en el es\u00f3fago)<\/li>\n\n\n\n<li>Mesotelioma pleural maligno (c\u00e1ncer del revestimiento del pulm\u00f3n)<\/li>\n\n\n\n<li>C\u00e1ncer g\u00e1strico (c\u00e1ncer de est\u00f3mago)<\/li>\n\n\n\n<li>C\u00e1ncer de la uni\u00f3n gastroesof\u00e1gica (c\u00e1ncer que se produce donde el es\u00f3fago se une al est\u00f3mago)<\/li>\n\n\n\n<li>Adenocarcinoma esof\u00e1gico (c\u00e1ncer que comienza en las c\u00e9lulas glandulares del es\u00f3fago)<\/li>\n<\/ul>\n\n\n\n<p>El Opdivo se utiliza com\u00fanmente para tratar el c\u00e1ncer avanzado o metast\u00e1sico que ha invadido otras partes del cuerpo y es resistente al tratamiento con terapias convencionales. A menudo se utiliza solo o combinado con otros tratamientos oncol\u00f3gicos, como inmunoterapia, quimioterapia y radioterapia.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-does-opdivo-work\"><span class=\"ez-toc-section\" id=\"How_Does_Opdivo_Work\"><\/span>\u00bfC\u00f3mo funciona Opdivo?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Opdivo contiene un f\u00e1rmaco activo llamado nivolumab, un&nbsp;<a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/cancer\/in-depth\/monoclonal-antibody\/art-20047808#:~:text=Monoclonal%20antibodies%20are%20laboratory%2Dproduced,wanted%2C%20such%20as%20cancer%20cells.\">anticuerpo monoclonal<\/a>&nbsp;Que funciona ayudando al sistema inmunitario a combatir las c\u00e9lulas cancerosas. Normalmente, nuestro sistema inmunitario cuenta con c\u00e9lulas especializadas, espec\u00edficamente linfocitos T, que pueden detectar y destruir las c\u00e9lulas cancerosas. Sin embargo, algunas c\u00e9lulas cancerosas producen prote\u00ednas llamadas PD-L1 y PD-L2 para evitar la detecci\u00f3n de los linfocitos T. Estas prote\u00ednas (PD-L1 y PD-L2) se unen a un receptor en los linfocitos T llamado PD-1 e inhiben su actividad, impidiendo as\u00ed que los linfocitos T ataquen a las c\u00e9lulas cancerosas y permiti\u00e9ndoles crecer y propagarse.<\/p>\n\n\n\n<p>El Opdivo est\u00e1 dise\u00f1ado para unirse al receptor PD-1 de los linfocitos T. Al unirse al receptor PD-1, impide que las prote\u00ednas de las c\u00e9lulas cancerosas (PD-L1 y PD-L2) se unan a los linfocitos T y los desactiven. Esto permite que los linfocitos T permanezcan activos y reconozcan y destruyan las c\u00e9lulas cancerosas.<\/p>\n\n\n\n<p>Al bloquear la uni\u00f3n de las prote\u00ednas PD-L1 y PD-L2, Opdivo aumenta la capacidad del sistema inmunol\u00f3gico para identificar y destruir las c\u00e9lulas cancerosas, ralentizando o deteniendo el crecimiento del tumor.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dosage-form-and-strengths\"><span class=\"ez-toc-section\" id=\"Dosage_Form_and_Strengths\"><\/span>Forma farmac\u00e9utica y concentraciones<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Opdivo est\u00e1 disponible en un vial de dosis \u00fanica que contiene una soluci\u00f3n incolora a amarillo p\u00e1lido con las siguientes concentraciones:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>40 mg\/4 ml&nbsp;<\/li>\n\n\n\n<li>100 mg\/10 ml<\/li>\n\n\n\n<li>120 mg\/12 ml<\/li>\n\n\n\n<li>240 mg\/24 ml<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-dosage\"><span class=\"ez-toc-section\" id=\"Dosage\"><\/span>Dosificaci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-dosing-information\"><span class=\"ez-toc-section\" id=\"Dosing_Information\"><\/span><strong>Informaci\u00f3n de dosificaci\u00f3n<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La dosificaci\u00f3n de Opdivo depende del tipo de c\u00e1ncer a tratar y de otros factores individuales, como el peso y el estado general de salud del paciente. Las dosis recomendadas de Opdivo como agente \u00fanico (monoterapia) en pacientes con diferentes tipos de c\u00e1ncer son las siguientes:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-as-a-single-agent-monotherapy\"><span class=\"ez-toc-section\" id=\"As_a_Single_Agent_Monotherapy\"><\/span><strong>Como agente \u00fanico (monoterapia)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La dosis intravenosa de Opdivo es de 240 mg una vez cada 2 semanas o 480 mg una vez cada 4 semanas, que se infunde durante 30 minutos en pacientes adultos con melanoma, c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as metast\u00e1sico, carcinoma de c\u00e9lulas renales avanzado, linfoma de Hodgkin cl\u00e1sico, carcinoma de c\u00e9lulas escamosas de cabeza y cuello, localmente avanzado o metast\u00e1sico.&nbsp;<a href=\"https:\/\/www.cancer.org\/cancer\/types\/bladder-cancer\/about\/what-is-bladder-cancer.html\">carcinoma urotelial<\/a>, carcinoma de c\u00e9lulas escamosas de es\u00f3fago y c\u00e1ncer colorrectal.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Para pacientes pedi\u00e1tricos con c\u00e1ncer colorrectal (que pesan 40 kg o m\u00e1s), Opdivo se administra por v\u00eda intravenosa cada 4 semanas a una dosis recomendada de 240 mg durante 30 minutos.<\/li>\n\n\n\n<li>Para pacientes pedi\u00e1tricos (12 a\u00f1os o m\u00e1s) con c\u00e1ncer colorrectal y que pesan menos de 40 kg, la dosis de Opdivo como agente \u00fanico es de 3 mg\/kg una vez cada 2 semanas, durante 30 minutos.&nbsp;<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-combined-with-other-therapies\"><span class=\"ez-toc-section\" id=\"Combined_With_Other_Therapies\"><\/span><strong>Combinado con otras terapias<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Las dosis intravenosas (IV) recomendadas de Opdivo en combinaci\u00f3n con otros tratamientos contra el c\u00e1ncer, como quimioterapia, inmunoterapia o radioterapia, son las siguientes:&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-for-metastatic-melanoma\"><strong>Para el melanoma metast\u00e1sico<\/strong><\/h4>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-combined-with-ipilimumab\"><strong>Combinado con ipilimumab<\/strong><\/h5>\n\n\n\n<p>Cuando se utiliza con ipilimumab, Opdivo se administra por v\u00eda intravenosa durante 30 minutos, una vez cada 3 semanas, a una dosis de 1 mg\/kg. Ipilimumab se administra el mismo d\u00eda por v\u00eda intravenosa durante 90 minutos a una dosis de 3 mg\/kg. El n\u00famero m\u00e1ximo de dosis de la terapia combinada no debe exceder cuatro. Tras completar cuatro dosis de la terapia combinada, se administra Opdivo solo.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-for-metastatic-non-small-cell-lung-cancer\"><strong>Para el c\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as metast\u00e1sico<\/strong><\/h4>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-combined-with-ipilimumab-0\"><strong>Combinado con ipilimumab<\/strong><\/h5>\n\n\n\n<p>El paciente recibe 3 mg\/kg de Opdivo por v\u00eda intravenosa durante 30 minutos cada 2 semanas, junto con ipilimumab, que se administra en una dosis de 1 mg\/kg por v\u00eda intravenosa durante 30 minutos cada 6 semanas. El tratamiento contin\u00faa hasta que la enfermedad progrese o hasta que se presenten efectos secundarios inaceptables. Si no hay progresi\u00f3n de la enfermedad, el tratamiento puede continuar hasta 2 a\u00f1os.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-for-gastric-cancer-esophageal-adenocarcinoma-and-gastroesophageal-junction-cancer\"><strong>Para el c\u00e1ncer g\u00e1strico, el adenocarcinoma esof\u00e1gico y el c\u00e1ncer de la uni\u00f3n gastroesof\u00e1gica<\/strong><\/h4>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-combined-with-fluoropyrimidine-and-platinum-containing-chemotherapy\"><strong>Combinado con quimioterapia que contiene fluoropirimidina y platino<\/strong><\/h5>\n\n\n\n<p>El Opdivo se administra por v\u00eda intravenosa cada 2 semanas a una dosis de 240 mg o cada 3 semanas a una dosis de 360 mg, junto con quimioterapia con fluoropirimidina y platino. El tratamiento puede durar hasta 2 a\u00f1os.&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-for-advanced-renal-cell-carcinoma\"><strong>Para el carcinoma avanzado de c\u00e9lulas renales<\/strong><\/h4>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-combined-with-ipilimumab-1\"><strong>Combinado con ipilimumab<\/strong><\/h5>\n\n\n\n<p>Cuando se utiliza con ipilimumab, Opdivo se administra por v\u00eda intravenosa cada 3 semanas a una dosis de 3 mg\/kg, junto con ipilimumab, que se administra por v\u00eda intravenosa a una dosis de 1 mg\/kg durante 30 minutos el mismo d\u00eda, hasta un m\u00e1ximo de cuatro dosis. Tras completar las cuatro dosis de la terapia combinada, Opdivo se administra solo durante un m\u00e1ximo de 2 a\u00f1os.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-combined-nbsp-with-nbsp-cabozantinib\"><strong>Conjunto<\/strong><strong>&nbsp;con&nbsp;<a href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/cabozantinib-cabometyx\/\">cabozantinib<\/a><\/strong><\/h5>\n\n\n\n<p>La dosis intravenosa de Opdivo es de 240 mg IV durante 30 minutos cada 2 semanas en combinaci\u00f3n con cabozantinib 40 mg por v\u00eda oral una vez al d\u00eda (sin alimentos).<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-for-hepatocellular-carcinoma\"><strong>Para el carcinoma hepatocelular<\/strong><\/h4>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-combined-with-ipilimumab-2\"><strong>Combinado con ipilimumab<\/strong><\/h5>\n\n\n\n<p>Opdivo e ipilimumab se administran conjuntamente hasta en cuatro dosis. Opdivo se administra cada tres semanas por v\u00eda intravenosa a una dosis de 1 mg\/kg, mientras que ipilimumab se administra el mismo d\u00eda por v\u00eda intravenosa a una dosis de 3 mg\/kg. Tras completar las cuatro dosis de la terapia combinada, Opdivo se administra solo.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-for-adults-and-pediatrics-with-colorectal-cancer\"><strong>Para adultos y ni\u00f1os con c\u00e1ncer colorrectal<\/strong><\/h4>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-combined-with-ipilimumab-3\"><strong>Combinado con ipilimumab<\/strong><\/h5>\n\n\n\n<p>Opdivo e ipilimumab se administran conjuntamente por v\u00eda intravenosa cada 3 semanas. Opdivo se administra en dosis de 3 mg\/kg y ipilimumab en dosis de 1 mg\/kg durante 30 minutos el mismo d\u00eda, hasta un m\u00e1ximo de cuatro dosis en adultos con un peso corporal igual o superior a 40 kg. Tras completar las cuatro dosis del tratamiento combinado, Opdivo debe administrarse solo.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-for-malignant-pleural-mesothelioma\"><strong>Para el mesotelioma pleural maligno<\/strong><\/h4>\n\n\n\n<h5 class=\"wp-block-heading\" id=\"h-combined-with-ipilimumab-4\"><strong>Combinado con ipilimumab<\/strong><\/h5>\n\n\n\n<p>Para pacientes adultos, la cantidad sugerida de Opdivo es de 360 mg\/kg por v\u00eda intravenosa, administrada cada 3 semanas, junto con ipilimumab, que tambi\u00e9n se administra por v\u00eda intravenosa en una dosis de 1 mg\/kg, administrada cada 6 semanas.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-is-opdivo-administered\"><span class=\"ez-toc-section\" id=\"How_Is_Opdivo_Administered\"><\/span>\u00bfC\u00f3mo se administra Opdivo?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El Opdivo se administra por v\u00eda intravenosa. La administraci\u00f3n intravenosa suele tardar entre 30 y 90 minutos. Este medicamento se administra lentamente cada 2 a 4 semanas.&nbsp;<\/p>\n\n\n\n<p>La dosis y frecuencia recomendadas de Opdivo pueden variar dependiendo de la condici\u00f3n espec\u00edfica que se est\u00e9 tratando y si se utiliza como tratamiento independiente o en combinaci\u00f3n con otros medicamentos contra el c\u00e1ncer.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-side-effects\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span>Efectos secundarios<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image is-style-default\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"279\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/opdivo-side-effects.jpg\" alt=\"A woman suffering from side effects from taking Opdivo\" class=\"wp-image-24687\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/opdivo-side-effects.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/opdivo-side-effects-300x199.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/opdivo-side-effects-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/opdivo-side-effects-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/opdivo-side-effects-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/opdivo-side-effects-280x186.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/11\/opdivo-side-effects-370x246.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>Los efectos secundarios de Opdivo pueden variar dependiendo de si se administra como monoterapia (solo) o combinado con otros medicamentos de inmunoterapia o quimioterapia.&nbsp;<strong>Efectos secundarios del Opdivo como tratamiento independiente<\/strong>&nbsp;(que podr\u00edan afectar a m\u00e1s de 1 de cada 10 personas) incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cansancio (fatiga o cansancio extremo)<\/li>\n\n\n\n<li>N\u00e1useas leves<\/li>\n\n\n\n<li>Dolores musculares y \u00f3seos<\/li>\n\n\n\n<li>Diarrea<\/li>\n\n\n\n<li>Tos<\/li>\n\n\n\n<li>Erupciones y picaz\u00f3n<\/li>\n\n\n\n<li>disminuci\u00f3n del apetito<\/li>\n\n\n\n<li>Dolor articular (artralgia)<\/li>\n\n\n\n<li>Aumentar la presi\u00f3n arterial<\/li>\n\n\n\n<li>Fiebre (pirexia)<\/li>\n\n\n\n<li>V\u00f3mitos<\/li>\n\n\n\n<li>dolores de cabeza<\/li>\n\n\n\n<li>Hinchaz\u00f3n<\/li>\n\n\n\n<li>Constipaci\u00f3n<\/li>\n\n\n\n<li>Dificultad para respirar (disnea)<\/li>\n\n\n\n<li>Dolor abdominal<\/li>\n\n\n\n<li>Infecciones de la garganta y la nariz<\/li>\n<\/ul>\n\n\n\n<p>Pacientes que reciben&nbsp;<strong>Opdivo combinado con ipilimumab<\/strong>&nbsp;Puede experimentar los siguientes efectos secundarios comunes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>niveles bajos de hormonas tiroideas (hipotiroidismo)<\/li>\n\n\n\n<li>Disminuci\u00f3n de peso<\/li>\n\n\n\n<li>Disminuci\u00f3n del apetito<\/li>\n\n\n\n<li>Constipaci\u00f3n<\/li>\n\n\n\n<li>Mareo<\/li>\n\n\n\n<li>Fatiga<\/li>\n\n\n\n<li>Diarrea<\/li>\n\n\n\n<li>N\u00e1useas<\/li>\n\n\n\n<li>Picaz\u00f3n (prurito)<\/li>\n\n\n\n<li>Dolor abdominal<\/li>\n\n\n\n<li>Tos con v\u00f3mitos<\/li>\n\n\n\n<li>Infecci\u00f3n del tracto respiratorio superior&nbsp;<\/li>\n<\/ul>\n\n\n\n<p>Pacientes que reciben&nbsp;<strong>Opdivo combinado con quimioterapia<\/strong>&nbsp;Puede experimentar los siguientes efectos secundarios comunes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>N\u00e1useas<\/li>\n\n\n\n<li>Disminuci\u00f3n del apetito<\/li>\n\n\n\n<li>Fatiga<\/li>\n\n\n\n<li>Erupci\u00f3n<\/li>\n\n\n\n<li>Constipaci\u00f3n<\/li>\n<\/ul>\n\n\n\n<p>Pacientes que reciben&nbsp;<strong>Opdivo combinado con ipilimumab y quimioterapia&nbsp;<\/strong>Puede experimentar los siguientes efectos secundarios:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>N\u00e1useas<\/li>\n\n\n\n<li>Disminuci\u00f3n del apetito<\/li>\n\n\n\n<li>Fatiga<\/li>\n\n\n\n<li>Erupciones y picaz\u00f3n<\/li>\n\n\n\n<li>Constipaci\u00f3n<\/li>\n\n\n\n<li>Dolor musculoesquel\u00e9tico<\/li>\n<\/ul>\n\n\n\n<p>Pacientes que reciben&nbsp;<strong>Opdivo combinado con&nbsp;<\/strong><strong>cabozantinib<\/strong>&nbsp;Puede experimentar los siguientes efectos secundarios:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Problemas de h\u00edgado<\/li>\n\n\n\n<li><a href=\"https:\/\/www.mdanderson.org\/cancerwise\/chemotherapy-side-effect--hand-foot-syndrome.h00-159459267.html#:~:text=Hand%2Dfoot%20syndrome%20(also%20called,and%20soles%20of%20the%20feet.\">S\u00edndrome de eritrodisestesia palmoplantar<\/a>&nbsp;(s\u00edndrome mano-pie)<\/li>\n\n\n\n<li>llagas en la boca<\/li>\n\n\n\n<li>Hipertensi\u00f3n<\/li>\n\n\n\n<li>Cambios en el sentido del gusto<\/li>\n\n\n\n<li>Dolor abdominal<\/li>\n\n\n\n<li>Fatiga<\/li>\n\n\n\n<li>Dolor musculoesquel\u00e9tico<\/li>\n\n\n\n<li>Sarpullido, enrojecimiento, dolor, hinchaz\u00f3n o ampollas en la palma y la planta del pie.<\/li>\n\n\n\n<li>Poco apetito<\/li>\n\n\n\n<li>Estomatitis<\/li>\n<\/ul>\n\n\n\n<p>Pacientes que reciben&nbsp;<strong>Opdivo combinado con fluoropirimidina y quimioterapia que contiene platino<\/strong>&nbsp;pueden experimentar los siguientes efectos secundarios durante su tratamiento:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dolor, entumecimiento, ardor u hormigueo en las manos o los pies.<\/li>\n\n\n\n<li>llagas en la boca<\/li>\n\n\n\n<li>Dolor musculoesquel\u00e9tico y abdominal<\/li>\n\n\n\n<li>Constipaci\u00f3n<\/li>\n\n\n\n<li>Sentirse cansado<\/li>\n\n\n\n<li>Diarrea<\/li>\n\n\n\n<li>V\u00f3mitos<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-precautions-when-taking-opdivo\"><span class=\"ez-toc-section\" id=\"Precautions_When_Taking_Opdivo\"><\/span>Precauciones al tomar Opdivo<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>No debe tomar Opdivo si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tiene antecedentes de enfermedades autoinmunes como lupus,&nbsp;<a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/living-with-crohns-disease-what-you-should-know\/\">enfermedad de Crohn<\/a>, o colitis ulcerosa.<\/li>\n\n\n\n<li>Ha recibido un trasplante de \u00f3rgano.<\/li>\n\n\n\n<li>Ha recibido quimioterapia o radioterapia en el pasado.<\/li>\n\n\n\n<li>Tiene trastornos nerviosos como el s\u00edndrome de Guillain-Barr\u00e9 o miastenia gravis.<\/li>\n\n\n\n<li>Tiene enfermedad del h\u00edgado.<\/li>\n\n\n\n<li>Est\u00e1 embarazada o planea quedar embarazada, ya que Opdivo causa toxicidad embriofetal.<\/li>\n\n\n\n<li>\u00bfEst\u00e1 amamantando a un ni\u00f1o o planea amamantarlo?<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-cost\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span>Costo<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La soluci\u00f3n intravenosa Opdivo (10 mg\/ml) cuesta aproximadamente $1272. Sin embargo, el costo puede variar seg\u00fan la farmacia que visite y su seguro m\u00e9dico actual. Podr\u00eda haber asistencia para el copago.&nbsp;<a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">Cont\u00e1ctanos<\/a>&nbsp;Si est\u00e1 interesado en asistencia financiera para Opdivo.<\/p>","protected":false},"excerpt":{"rendered":"<p>Opdivo es el nombre comercial del medicamento nivolumab, un tipo de f\u00e1rmaco de inmunoterapia utilizado para tratar ciertos tipos de c\u00e1ncer. Opdivo fue aprobado por primera vez por la FDA en 2014 para tratar el melanoma avanzado que no responde a otros tipos de tratamientos.<\/p>","protected":false},"author":13,"featured_media":24681,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[64],"tags":[],"class_list":["post-24679","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-discontinued"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Opdivo: A Versatile Drug That Fights Multiple Types of Cancer - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about Opdivo and how it treats multiple types of cancer. Topics include how the drug works, dosage, side effects, and cost.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opdivo: A Versatile Drug That Fights Multiple Types of Cancer - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about Opdivo and how it treats multiple types of cancer. Topics include how the drug works, dosage, side effects, and cost.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-28T19:37:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T21:44:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/\"},\"author\":{\"name\":\"Dr. Saba Rassouli, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\"},\"headline\":\"Opdivo: A Versatile Drug That Fights Multiple Types of Cancer\",\"datePublished\":\"2023-11-28T19:37:00+00:00\",\"dateModified\":\"2026-03-19T21:44:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/\"},\"wordCount\":1578,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg\",\"articleSection\":[\"Discontinued\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/\",\"name\":\"Opdivo: A Versatile Drug That Fights Multiple Types of Cancer - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg\",\"datePublished\":\"2023-11-28T19:37:00+00:00\",\"dateModified\":\"2026-03-19T21:44:52+00:00\",\"description\":\"Learn about Opdivo and how it treats multiple types of cancer. Topics include how the drug works, dosage, side effects, and cost.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Immunotherapy Drug for Treating Different Types of Cancer\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/discontinued\\\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opdivo: A Versatile Drug That Fights Multiple Types of Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\",\"name\":\"Dr. Saba Rassouli, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"caption\":\"Dr. Saba Rassouli, PharmD\"},\"description\":\"Dr. Saba Rassouli, PharmD was born and raised in Iran. She received her pharmacy degree from Marshall B. Ketchum University in 2022, where she graduated cum laude. The most rewarding part of her job is having the opportunity to care for each patient as if they were family and hearing about how happy and satisfied they are with the services provided by AmeriPharma. In her free time, she likes to go on walks, read books, and try different restaurants and foods.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/saba-rassouli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Opdivo: Un f\u00e1rmaco vers\u00e1til que combate m\u00faltiples tipos de c\u00e1ncer - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Aprenda sobre el Opdivo y c\u00f3mo trata diversos tipos de c\u00e1ncer. Los temas incluyen c\u00f3mo funciona el f\u00e1rmaco, la dosis, los efectos secundarios y el costo.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/","og_locale":"es_MX","og_type":"article","og_title":"Opdivo: A Versatile Drug That Fights Multiple Types of Cancer - AmeriPharma\u00ae Specialty Care","og_description":"Learn about Opdivo and how it treats multiple types of cancer. Topics include how the drug works, dosage, side effects, and cost.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-11-28T19:37:00+00:00","article_modified_time":"2026-03-19T21:44:52+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg","type":"image\/jpeg"}],"author":"Dr. Saba Rassouli, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Saba Rassouli, PharmD","Est. reading time":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/"},"author":{"name":"Dr. Saba Rassouli, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01"},"headline":"Opdivo: A Versatile Drug That Fights Multiple Types of Cancer","datePublished":"2023-11-28T19:37:00+00:00","dateModified":"2026-03-19T21:44:52+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/"},"wordCount":1578,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg","articleSection":["Discontinued"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/","name":"Opdivo: Un f\u00e1rmaco vers\u00e1til que combate m\u00faltiples tipos de c\u00e1ncer - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg","datePublished":"2023-11-28T19:37:00+00:00","dateModified":"2026-03-19T21:44:52+00:00","description":"Aprenda sobre el Opdivo y c\u00f3mo trata diversos tipos de c\u00e1ncer. Los temas incluyen c\u00f3mo funciona el f\u00e1rmaco, la dosis, los efectos secundarios y el costo.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg","width":1280,"height":853,"caption":"Immunotherapy Drug for Treating Different Types of Cancer"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/discontinued\/opdivo-a-versatile-drug-that-fights-multiple-types-of-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Opdivo: A Versatile Drug That Fights Multiple Types of Cancer"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01","name":"Dra. Saba Rassouli, Farmac\u00e9utica","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","caption":"Dr. Saba Rassouli, PharmD"},"description":"La Dra. Saba Rassouli, doctora en farmacia, naci\u00f3 y creci\u00f3 en Ir\u00e1n. Obtuvo su t\u00edtulo en farmacia en la Universidad Marshall B. Ketchum en 2022, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es tener la oportunidad de atender a cada paciente como si fuera de su familia y escuchar lo contentos y satisfechos que est\u00e1n con los servicios de AmeriPharma. En su tiempo libre, le gusta pasear, leer y probar diferentes restaurantes y comidas.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"uagb_comment_info":0,"uagb_excerpt":"Opdivo is a brand name for the medication nivolumab, which is a type of immunotherapy drug used to treat certain types of cancer. Opdivo was first approved by the FDA in 2014 to treat advanced melanoma that is unresponsive to other types of treatments.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/01\/Opdivo-A-Versatile-Drug-That-Fights-Multiple-Types-of-Cancer.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/discontinued\/\" rel=\"category tag\">Discontinued<\/a>","rttpg_excerpt":"Opdivo is a brand name for the medication nivolumab, which is a type of immunotherapy drug used to treat certain types of cancer. Opdivo was first approved by the FDA in 2014 to treat advanced melanoma that is unresponsive to other types of treatments.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/24679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=24679"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/24679\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/24681"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=24679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=24679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=24679"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}